EUVIMEDEUVIMED entdecken
Crossref

The impact of intraoperative frozen section in patients with clinically node-negative breast cancer (cN0/ycN0) who received neoadjuvant systemic therapy

Uwe Güth, Constanze Elfgen, Shadi Najaf Zadeh, Simon Meier, Zsuzsanna Varga, Marianne Tinguely, Bärbel Papassotiropoulos, Kavitha Däster, Christoph J Tausch

European Journal of Surgical Oncology · 2023

DOI: 10.1016/j.ejso.2023.04.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2023. Verfasst von Uwe Güth und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brust-Zentrum Zürich, Department of Breast Surgery, Seefeldstrasse 214, CH-8008, Zurich, Switzerland; University of Basel, Faculty of Medicine, Kling…. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: When surgical axillary staging reveals residual metastatic deposits in breast cancer (BC) patients who had received neoadjuvant chemotherapy (NACT), axillary lymphonodectomy is indicated. In this study, we investigate whether it is reasonable to perform intraoperative frozen section (FS) of the removed sentinel lymph nodes (SLNs) in cases where NACT had been administered in patients who had a clinically negative nodal status at the time of diagnosis. PATIENTS AND METHODS: We analyzed data from 101 BCE patients with 103 carcinomas who were diagnosed between 2014 and 2021 and met the above-mentioned criteria. RESULTS: In three cases (2.8% of the study group), histologically active tumor tissue was detected in the removed axillary LNs. Discontinuation of therapy/the use of a low-dose NACT regimen was a significant factor for positive LNs (p = 0.02) at the subsequent surgical procedure; tumor progression during therapy approached borderline significance (p = 0.058). Among patients who had completed NACT with the planned standard dose regimen, and in which the primary tumors showed a response to therapy (n = 94), only one case had histologically detected residual metastases in the SLNs. CONCLUSIONS: Certified breast centers aim to improve the outcome of the patients. However, these specialized centers should also focus on economic aspects. This means that diagnostic and therapeutic procedures should be continuously critically reviewed in order to avoid unnecessary expenses. In BC patients with clinically node negative disease who completed NACT as planned and in which the tumor showed a good response to therapy, time consuming and costly FS of the SLNs removed should be omitted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleSentinel Lymph Node BiopsyNeoadjuvant TherapyFrozen SectionsLymphatic MetastasisAxillaLymph Node ExcisionLymph Nodes

Stichwörter der Autor:innen

Breast cancerCertified breast centersFrozen sectionMedical-economic responsibilityNeoadjuvant chemotherapySentinel lymph node biopsy

Autor:innen und Institutionen

  • Brust-Zentrum Zürich, Department of Breast Surgery, Seefeldstrasse 214, CH-8008, Zurich, Switzerland; University of Basel, Faculty of Medicine, Klingelbergstrasse 61, CH-4056, Basel, Switzerland. Electronic address: uwe…
  • Brust-Zentrum Zürich, Department of Breast Surgery, Seefeldstrasse 214, CH-8008, Zurich, Switzerland; University of Witten/Herdecke, Faculty of Medicine, Alfred-Herrhausen-Strasse 50, 58448, Witten, Germany.
  • Brust-Zentrum Zürich, Department of Breast Surgery, Seefeldstrasse 214, CH-8008, Zurich, Switzerland.
  • Institute of Pathology and Molecular Pathology, University Hospital of Zurich, Schmelzbergstrasse 12, CH-8091, Zurich, Switzerland.
  • Institute of Pathology Enge, Hardturmstrasse 133, CH-8055, Zurich, Switzerland; University of Zurich, Medical Faculty, Pestalozzistrasse 3, CH-8032, Zurich, Switzerland.
  • Brust-Zentrum Zürich, Department of Breast Surgery, Seefeldstrasse 214, CH-8008, Zurich, Switzerland; University of Basel, Faculty of Medicine, Klingelbergstrasse 61, CH-4056, Basel, Switzerland.

Zitieren

APA

Güth, U., Elfgen, C., Zadeh, S. N., Meier, S., Varga, Z., Tinguely, M., Papassotiropoulos, B., Däster, K., & Tausch, C. J. (2023). The impact of intraoperative frozen section in patients with clinically node-negative breast cancer (cN0/ycN0) who received neoadjuvant systemic therapy. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2023.04.017

Vancouver

Güth U, Elfgen C, Zadeh SN, Meier S, Varga Z, Tinguely M, et al. The impact of intraoperative frozen section in patients with clinically node-negative breast cancer (cN0/ycN0) who received neoadjuvant systemic therapy. European Journal of Surgical Oncology. 2023. doi:10.1016/j.ejso.2023.04.017

BibTeX
@article{Gth2023,
  author = {Güth, Uwe and Elfgen, Constanze and Zadeh, Shadi Najaf and Meier, Simon and Varga, Zsuzsanna and Tinguely, Marianne and Papassotiropoulos, Bärbel and Däster, Kavitha and Tausch, Christoph J},
  title = {The impact of intraoperative frozen section in patients with clinically node-negative breast cancer (cN0/ycN0) who received neoadjuvant systemic therapy},
  journal = {European Journal of Surgical Oncology},
  year = {2023},
  doi = {10.1016/j.ejso.2023.04.017}
}
Kostenlos starten →